Advances in immunology, biotechnology, and phar-maceutical science have resulted in an unprecedented number of medications with potential application to the treatment of Crohn's …
P Gionchetti, A Dignass, S Danese… - Journal of Crohn's …, 2017 - academic.oup.com
This paper is the second in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management …
Background Surgical resection of the diseased bowel in C rohn's disease is unfortunately not curative, and postoperative recurrence remains a problem in these patients. Aim To …
M Regueiro, W Schraut, L Baidoo, KE Kip… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Crohn's disease commonly recurs after intestinal resection. We evaluated whether the administration of infliximab after resective intestinal surgery for …
WC Lim, Y Wang, JK MacDonald… - Cochrane Database of …, 2016 - cochranelibrary.com
Background Randomized trials investigating the efficacy of aminosalicylates for the treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A …
VW Fazio, F Marchetti, JM Church, JR Goldblum… - Annals of …, 1996 - journals.lww.com
Objective The authors assess the effect of surgical margin width on recurrence rates after intestinal resection for Crohn's Disease (CD). Background The optimal width of margins …
R Caprilli, MA Gassull, JC Escher, G Moser… - Gut, 2006 - gut.bmj.com
This third section of the European Crohn's and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns postoperative recurrence, fistulating disease …
CD Trivedi, CS Pitchumoni - Journal of clinical gastroenterology, 2005 - journals.lww.com
Methods: We searched the National Library of Medicine/Pubmed for reported cases of DIP from 1966 to April 30, 2004. Medications implicated in AP are classified based on the …
L Vuitton, P Marteau, WJ Sandborn, BG Levesque… - Gut, 2016 - gut.bmj.com
Background Crohn's disease (CD) is a chronic disabling and progressive IBD. Only strategies looking beyond symptoms and based on tight monitoring of objective signs of …